{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:29:22Z","timestamp":1793687362852,"version":"4.5.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xcrm.2026.102875","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:48:52Z","timestamp":1781794132000},"page":"102875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Negative effects of semaglutide on bone in obese mice"],"prefix":"10.1016","volume":"7","author":[{"given":"Katelyn","family":"Eisner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2721-4430","authenticated-orcid":false,"given":"Stewart","family":"Jeromson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawkab","family":"Tahboub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3867-8901","authenticated-orcid":false,"given":"David C.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102875_bib1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-Weekly Semaglutide in Adults with Overweight or Obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102875_bib2","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/s41591-024-02996-7","article-title":"Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial","volume":"30","author":"Ryan","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102875_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tcm.2021.12.008","article-title":"Semaglutide for the treatment of obesity","volume":"33","author":"Chao","year":"2023","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.xcrm.2026.102875_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/dom.14255","article-title":"Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes","volume":"23","author":"Gibbons","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.xcrm.2026.102875_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1249\/MSS.0000000000001074","article-title":"Effects of Weight Loss on Lean Mass, Strength, Bone, and Aerobic Capacity","volume":"49","author":"WEISS","year":"2017","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.xcrm.2026.102875_bib6","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/oby.24274","article-title":"Semaglutide-induced weight loss improves mitochondrial energy efficiency in skeletal muscle","volume":"33","author":"Choi","year":"2025","journal-title":"Obesity"},{"key":"10.1016\/j.xcrm.2026.102875_bib7","article-title":"Semaglutide impacts skeletal muscle to a similar extent as caloric restriction in mice with diet-induced obesity","author":"Jeromson","year":"2025","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.xcrm.2026.102875_bib8","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.cmet.2025.07.004","article-title":"Unexpected effects of semaglutide on skeletal muscle mass and force-generating capacity in mice","volume":"37","author":"Karasawa","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.102875_bib9","article-title":"Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans","volume":"7","author":"Langer","year":"2026","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.102875_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2025.117690","article-title":"01\/01). In C57BL\/6J mice, weight loss in previously obese mice reduced bone mass and shifted the cortical bone metabolome","volume":"202","author":"Chlebek","year":"2026","journal-title":"Bone"},{"key":"10.1016\/j.xcrm.2026.102875_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jbmr.2701","article-title":"Effect of Two-Year Caloric Restriction on Bone Metabolism and Bone Mineral Density in Non-Obese Younger Adults: A Randomized Clinical Trial","volume":"31","author":"Villareal","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.xcrm.2026.102875_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102624","article-title":"Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial","volume":"72","author":"Hansen","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.xcrm.2026.102875_bib13","article-title":"Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes","volume":"10","author":"Lu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.102875_bib14","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jbmr.1898","article-title":"Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats","volume":"28","author":"Ma","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.xcrm.2026.102875_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/oby.2011.263","article-title":"A Losing Battle: Weight Regain Does Not Restore Weight Loss-Induced Bone Loss in Postmenopausal Women","volume":"19","author":"Villalon","year":"2011","journal-title":"Obesity"},{"key":"10.1016\/j.xcrm.2026.102875_bib16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/jbmr.2539","article-title":"Establishing biomechanical mechanisms in mouse models: practical guidelines for systematically evaluating phenotypic changes in the diaphyses of long bones","volume":"30","author":"Jepsen","year":"2015","journal-title":"J. Bone Miner. Res."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:49:25Z","timestamp":1786481365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126002922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666379126002922"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102875","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Negative effects of semaglutide on bone in obese mice","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102875"}}